在右侧结肠癌中加速表观遗传年龄预测了有利的结果
Qin Ye1, Ping Song1, Wangxiong Hu2
1Department of Nursing, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Clinical epigenetics
|December 30, 2025
概括
表观遗传加快年龄 (EAA) 在右侧和左侧结直肠癌 (CRC) 之间有所不同. EAA是CRC预后和向治疗的潜在生物标志物,提供了CRC异质性的见解.
科学领域:
- 表观遗传学和衰老研究研究.
- 癌症生物学和基因组学
- 瘤学和临床研究.
背景情况:
- DNA甲基化年龄 (epiAge) 是一个已验证的衰老和癌症的生物标志物.
- 大肠直肠癌 (CRC) 是异质的,按瘤位置分类:左侧 (LCC),右侧 (RCC) 和直肠.
- 需要澄清表观遗传衰老加速 (EAA) 和CRC特征/结果之间的关系.
研究的目的:
- 调查EAA与CRC瘤位置 (LCC与RCC) 的关联.
- 探索EAA与CRC的临床特征和患者存活率的相关性.
- 评估EAA作为CRC异质性和预后的潜在生物标志物.
主要方法:
- 在548个CRC样本上使用四种模型 (Horvath2013,PhenoAge,ZhangQ2019,EpiTOC) 估计EpiAge (96个结对瘤/正常,356个TCGA瘤).
- 在LCC和RCC之间比较EpiAge和EAA.
- 记录等级测试来评估EAA与LCC和RCC存活率的关联.
主要成果:
- 与LCC相比,在RCC中观察到显著更高的epiAge (P=0.00025).
- 在女性和微卫星不稳定性高的RCC中EAA升高,并在RCC和LCC中显示出明显的特定阶段模式.
- EAA证明了与RCC死亡率的显著负相关性和与LCC死亡率的积极相关性.
结论:
- 从生物衰老的角度来看,EAA是理解CRC异质性的宝贵生物标志物.
- EAA可以帮助预后判断,并指导针对CRC的向治疗策略.
- 这些发现突显了EAA在结直肠癌个性化瘤学的潜力.
相关概念视频
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K


